Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
To test the feasibility and acceptability of AILI and associated research procedures among emerging adult cancer survivors (EACS, N=16) age 18-29.
Full description
This is a single-arm pilot trial designed to assess the feasibility and acceptability of an anti-inflammatory lifestyle intervention (AILI) for emerging adults (EA) adapted for emerging adult cancer survivors (EACS).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
16 participants in 1 patient group
Loading...
Central trial contact
Massey Cancer Prevention & Control Team; Tyler Phillips
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal